Innovative Swiss-German R&D firm seeks funding partner for advanced medical cannabis inhalation technology
Highly-specialized, Swiss-German R&D firm first to market with disruptive, advanced medical inhaler for clean cannabis extracts seeks strategic funding partner
Listing ID:
15959335429
Licence(s) Held:
N/A
Seeking strategic equity partner to fund up to ~ €1.5 million for accelerated development
Listing Details:
A German R&D company focused on developing vaporizer technology as a medical device for liquid cannabis extracts aiming to solve the core issues medical inhalation today
The technology excels in precisely evaporating small to high dosages in a single inhalation, ensuring optimal particle size for effective lung delivery
Different dosages will rely on dose specific cartridges, all working on the same inhalation platform technology
The technology is currently patent-pending, with anticipated patent grants in Europe, USA and Australia slated in 2024 or 2025
ISO 13485 certification to be certified in Q2 2024
Experienced, industry-leading international team possessing profound knowledge in medical/pharma R&D, expertise in inhalation technologies, and a strong background in the medical cannabis regulatory field
The company specializes in the development and sale of customized medical inhalers, achieving sustainable profits through strategic licensing agreements with pharmaceutical customers
Company is seeking strategic funding partner for accelerated development and bringing the product to market
15959335429
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
28971289009
Court-Approved Sale & Investment Solicitation Opportunity – Noble Growth Corp. & Noble Growth Alberta LP
Opportunity to acquire, invest in, restructure, or refinance a fully licensed cannabis cultivation, processing, branded products, and medical cannabis platform through a Court-approved Sale and Investment Solicitation Process (SISP) under CCAA. This offering provides a potential "clean slate" entry into the Canadian and international cannabis markets through a debt-free acquisition structure.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o
44498920359
Early-Stage UK Medical Cannabis Platform – Licensed Market Entry Opportunity
Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.